<VariationArchive RecordType="classified" VariationID="527213" VariationName="NM_000138.5(FBN1):c.5756del (p.Gly1919fs)" VariationType="Deletion" Accession="VCV000527213" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-12-11" DateCreated="2018-05-28" MostRecentSubmission="2018-05-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="529441" VariationID="527213">
      <GeneList>
        <Gene Symbol="FBN1" FullName="fibrillin 1" GeneID="2200" HGNC_ID="HGNC:3603" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q21.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="48408313" stop="48645709" display_start="48408313" display_stop="48645709" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="48700502" stop="48937984" display_start="48700502" display_stop="48937984" Strand="-" />
          </Location>
          <OMIM>134797</OMIM>
          <Haploinsufficiency last_evaluated="2019-12-04" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FBN1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2019-12-04" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FBN1">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000138.5(FBN1):c.5756del (p.Gly1919fs)</Name>
      <CanonicalSPDI>NC_000015.10:48446737:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q21.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="48446738" stop="48446738" display_start="48446738" display_stop="48446738" variantLength="1" positionVCF="48446737" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="48738935" stop="48738935" display_start="48738935" display_stop="48738935" variantLength="1" positionVCF="48738934" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>G1919fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.48446739del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.48446739del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.48738936del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.48738936del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008805.2" sequenceAccession="NG_008805" sequenceVersion="2" change="g.204051del">
            <Expression>NG_008805.2:g.204051del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000138.5" sequenceAccession="NM_000138" sequenceVersion="5" change="c.5756del" MANESelect="true">
            <Expression>NM_000138.5:c.5756del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000129.3" sequenceAccession="NP_000129" sequenceVersion="3" change="p.Gly1919fs">
            <Expression>NP_000129.3:p.Gly1919fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_778" sequenceAccession="LRG_778">
            <Expression>LRG_778:g.204051del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000138.4" sequenceAccession="NM_000138" sequenceVersion="4" change="c.5756delG">
            <Expression>NM_000138.4:c.5756delG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658798345" DB="ClinGen" />
        <XRef Type="rs" ID="1555395825" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000138.5(FBN1):c.5756del (p.Gly1919fs) AND multiple conditions" Accession="RCV000632023" Version="1">
        <ClassifiedConditionList TraitSetID="10731">
          <ClassifiedCondition DB="MedGen" ID="C4707243">Familial thoracic aortic aneurysm and aortic dissection</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0024796">Marfan syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-11-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-11-27" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-05-28" MostRecentSubmission="2018-05-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="10731" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16634" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Thoracic aortic aneurysm and aortic dissection</ElementValue>
                <XRef ID="Thoracic+Aortic+Aneurysms+and+Aortic+Dissections/9386" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Familial thoracic aortic aneurysm and aortic dissection</ElementValue>
                <XRef ID="MONDO:0019625" DB="MONDO" />
                <XRef ID="91387" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thoracic aortic aneurysms and dissections</ElementValue>
                <XRef ID="UWMG_7008129" DB="CSER _CC_NCGL, University of Washington" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TAAD</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">EDS</ElementValue>
              </Symbol>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301299</ID>
                <ID Source="BookShelf">NBK1120</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="CCS, 2014">
                <ID Source="PubMed">24882528</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ESC, 2014">
                <ID Source="PubMed">25173340</ID>
              </Citation>
              <XRef ID="91387" DB="Orphanet" />
              <XRef ID="C4707243" DB="MedGen" />
              <XRef ID="MONDO:0019625" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS607086" DB="OMIM" />
            </Trait>
            <Trait ID="2645" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MARFAN SYNDROME, TYPE I</ElementValue>
                <XRef Type="MIM" ID="154700" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Marfan's syndrome</ElementValue>
                <XRef ID="Marfan+syndrome/4466" DB="Genetic Alliance" />
                <XRef ID="19346006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Marfan syndrome</ElementValue>
                <XRef ID="MONDO:0007947" DB="MONDO" />
                <XRef ID="19346006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Marfan syndrome type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Marfan syndrome, classic</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MFS</ElementValue>
                <XRef Type="MIM" ID="154700" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">MFS1</ElementValue>
                <XRef Type="MIM" ID="154700" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6975" />
                <XRef ID="6975" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">FBN1-Related Marfan Syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">FBN1-related Marfan syndrome (Marfan syndrome), a systemic disorder of connective tissue with a high degree of clinical variability, comprises a broad phenotypic continuum ranging from mild (features of Marfan syndrome in one or a few systems) to severe and rapidly progressive neonatal multiorgan disease. Cardinal manifestations involve the ocular, skeletal, and cardiovascular systems. Ocular findings include myopia (&gt;50% of affected individuals); ectopia lentis (seen in approximately 60% of affected individuals); and an increased risk for retinal detachment, glaucoma, and early cataracts. Skeletal system manifestations include bone overgrowth and joint laxity; disproportionately long extremities for the size of the trunk (dolichostenomelia); overgrowth of the ribs that can push the sternum in (pectus excavatum) or out (pectus carinatum); and scoliosis that ranges from mild to severe and progressive. The major morbidity and early mortality in Marfan syndrome relate to the cardiovascular system and include dilatation of the aorta at the level of the sinuses of Valsalva (predisposing to aortic tear and rupture), mitral valve prolapse with or without regurgitation, tricuspid valve prolapse, and enlargement of the proximal pulmonary artery. Severe and prolonged regurgitation of the mitral and/or aortic valve can predispose to left ventricular dysfunction and occasionally heart failure. With proper management, the life expectancy of someone with Marfan syndrome approximates that of the general population.</Attribute>
                <XRef ID="NBK1335" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301510</ID>
                <ID Source="BookShelf">NBK1335</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2010">
                <ID Source="pmc">2987429</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG, 2012">
                <ID Source="PubMed">22237449</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="CSANZ, 2007">
                <ID Source="PubMed">17188935</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="AHA, 2004">
                <ID Source="PubMed">15184297</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2007">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_Marfan.pdf</URL>
                <CitationText>Orphanet, Marfan Syndrome, 2007</CitationText>
              </Citation>
              <Citation Type="Recommendation" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Loeys et al., 2010">
                <ID Source="PubMed">20591885</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="CCS, 2014">
                <ID Source="PubMed">24882528</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ESC, 2014">
                <ID Source="PubMed">25173340</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="AAP, 2013">
                <ID Source="PubMed">24081994</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="CSANZ, 2017">
                <ID Source="PubMed">28161018</ID>
              </Citation>
              <XRef ID="284963" DB="Orphanet" />
              <XRef ID="558" DB="Orphanet" />
              <XRef ID="C0024796" DB="MedGen" />
              <XRef ID="MONDO:0007947" DB="MONDO" />
              <XRef Type="MIM" ID="154700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1462576" SubmissionDate="2018-04-02" DateLastUpdated="2018-05-28" DateCreated="2018-05-28">
        <ClinVarSubmissionID localKey="3107651|MedGen:C0024796;CN118826" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000753126" DateUpdated="2018-05-28" DateCreated="2018-05-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-11-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This sequence change creates a premature translational stop signal (p.Gly1919Valfs*11) in the FBN1 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with FBN1-related disease. Loss-of-function variants in FBN1 are known to be pathogenic (PMID: 17657824, 19293843). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FBN1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000138.4:c.5756delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0024796" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN118826" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB3864685</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1462576" TraitType="Disease" MappingType="XRef" MappingValue="CN118826" MappingRef="MedGen">
        <MedGen CUI="C4707243" Name="Familial thoracic aortic aneurysm and aortic dissection" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1462576" TraitType="Disease" MappingType="XRef" MappingValue="C0024796" MappingRef="MedGen">
        <MedGen CUI="C0024796" Name="Marfan syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

